OTC veterinary drugs market seen reaching $13.57 billion by 2030
The Business Research Company projects the global OTC veterinary drugs market will grow from $8.93 billion in 2025 to $13.57 billion by 2030, driven by pet ownership, livestock demand and broader access through retail and e-commerce. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.
Why it matters: - The OTC veterinary drugs market is expanding as more pet owners and livestock operators look for accessible, lower-friction treatment options. - Growth in preventive care, supplements and e-commerce could reshape how animal health products are bought and used. - The market outlook points to continued demand even as the industry works to reduce antimicrobial resistance through alternatives.
What happened: - The Business Research Company said the global over-the-counter veterinary drugs market is forecast to rise from $8.93 billion in 2025 to $9.7 billion in 2026. - The market is projected to reach $13.57 billion by 2030. - The report pegs the 2025-2030 compound annual growth rate at 8.8%. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The company published a market report and offered a free sample and full report online: Download a free sample and View the full report.
The details: - The historical growth rate for the market was 8.5%. - Growth drivers in the historical period included rising pet ownership, a growing global livestock population and wider retail availability of veterinary pharmaceuticals. - Additional historical drivers included greater awareness of animal health and hygiene and the expansion of animal healthcare infrastructure in rural areas. - Future growth is expected to be supported by preventive animal healthcare, e-commerce sales, higher spending on companion animal health and more interest in nutraceuticals and supplements. - The report also cites efforts to combat antimicrobial resistance through OTC alternatives. - The market is seeing more use of OTC antiparasitic and anti-infective drugs. - Nutraceutical OTC supplements for immune function and joint health are gaining traction. - Dermatological OTC products for skin and coat conditions are also growing in popularity. - Broad-spectrum OTC formulations are being used more often for preventive animal health management. - OTC veterinary drugs are medications that animal owners can buy without a veterinarian’s prescription. - These products are intended for treatment, prevention or management of common animal health issues. - The report says these drugs are safe and effective when used as directed on the packaging. - The regional scope of the report includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The 2026 report additions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables.
Between the lines: - The strongest demand signals are coming from routine, consumer-friendly animal care rather than complex veterinary treatment. - E-commerce and retail channels are making OTC animal health products easier to buy, which could widen the market beyond traditional veterinary visits. - The pet-health growth story is closely tied to household ownership trends, especially in large markets like the U.S.
What's next: - The market’s trajectory will likely depend on how quickly preventive care and supplement categories scale across regions. - E-commerce penetration and pet spending trends will be key indicators to watch through 2030. - Regulatory and public-health pressure around antimicrobial resistance could also influence product mix and demand.
The bottom line: - OTC veterinary drugs are moving from a niche convenience category to a broader animal-health growth market, with strong demand tied to pets, livestock and easier access to care.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Economic Digest of Europe
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.